Table 1.

Patient and tumor characteristics

Patient/tumor variable (n = 25)No. (%) or median (range)
Female sex15 (60.0)
Age, y62 (50–75)
Adenocarcinoma (vs. squamous cell carcinoma)19 (76.0)
Stage IIIB (vs. other)8 (32.0)
Proton beam therapy (vs. X-ray radiotherapy)12 (48.0)
Chemotherapy modality
 Carboplatin + paclitaxel16 (64.0)
 Cisplatin + etoposide9 (36.0)
Primary MTV, cm327 (2–396)
SUVmax, g/cm311 (3–32)
SUVmean, g/cm36 (2–16)
TLG, g247 (5–4,408)
Ring/concave uptake pattern (vs. foci/convex)12 (48.0)
Time from pre-RT PET to mid-RT PET, d26 (16–51)
Time from pre-RT PET to RT start, d10 (1–33)